<prompt> Please answer with one of the option in the bracket. Write reasoning in between . Write answer in between .Q:A pharmaceutical company is studying a new drug that inhibits the glucose transporter used by intestinal enterocytes to absorb glucose into the body. The drug was designed such that it would act upon the glucose transporter similarly to how cyanide acts upon cytochrome proteins. During pre-clinical studies, the behavior of this drug on the activity of the glucose transporter is examined. Specifically, enterocyte cells are treated with the drug and then glucose is added to the solution at a concentration that saturates the activity of the transporter. The transport velocity and affinity of the transporters under these conditions are then measured. Compared to the untreated state, which of the following changes would most likely be seen in these transporters after treatment?? A: Decreased Km and decreased Vmax, B: Increased Km and decreased Vmax, C: Increased Km and unchanged Vmax, D: Unchanged Km and decreased Vmax, E: Unchanged Km and unchanged Vmax,  <response>: This is a question about the effects of an inhibitor drug on the kinetics of a glucose transporter. It states that the drug acts similarly to cyanide, which binds irreversibly to cytochrome proteins, inhibiting their activity. The question provides information about measuring the transport velocity Vmax and affinity Km of the transporter after treatment with the drug and in the presence of saturating glucose concentrations. The correct answer should reflect the expected changes in Km and Vmax for an irreversible inhibitor. An irreversible inhibitor decreases Vmax by reducing the total amount of active transporters. It does not affect the affinity, so Km remains unchanged.D: Unchanged Km and decreased Vmax 